IMMUTEP Aktie

 >IMMUTEP Aktienkurs 
0.16 EUR    (Tradegate)
Ask: 0.16 EUR / 10000 Stück
Bid: 0.15 EUR / 10000 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
>IMMUTEP Performance
1 Woche: +2,5%
1 Monat: +8,0%
3 Monate: +31,7%
6 Monate: +63,6%
1 Jahr: +839,1%
laufendes Jahr: -1,2%
>IMMUTEP Aktie
Name:  IMMUTEP LTD
Land:  Australien
Sektor:  Gesundheit
ISIN/ Wkn:  AU000000IMM6 / A2H81H
Symbol/ Ticker:  YP1B (Frankfurt)
Kürzel:  FRA:YP1B, YP1B.F, YP1B:GR
Index:  -
Webseite:  https://www.immutep.com/
Marktkapitalisierung:  73.87 Mio. EUR
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -0.003 EUR
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  23.40% / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  12.96 / 3.58 / -
Gewinnm./ Eigenkapitalr.:  -98.03% / -46.69%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Suchwörter:  IMMUTEP
Letzte Datenerhebung:  28.10.20
>IMMUTEP Eigentümer
Aktien: 492.87 Mio. St.
f.h. Aktien: 453.04 Mio. St.
Insider Eigner: 6.41%
Instit. Eigner: 6.85%
Leerverk. Aktien: -
>IMMUTEP Peer Group

 
29.10.20 - 13:48
Immutep to Collaborate with LabCorp to Develop Oncology Services and Products (GlobeNewswire EN)
 
SYDNEY, Australia, Oct. 29, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to announce that it has entered into a Li...
23.10.20 - 14:12
Immutep Announces the Start of an Investigator-Initiated Phase II Study in COVID-19 Patients (GlobeNewswire EN)
 
SYDNEY, Australia, Oct. 23, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), is pleased to announce it has signed a Material Transfer Agreement (“Agreement”) with the University Hospital Pils...
22.10.20 - 06:42
Why is the Immutep (ASX:IMM) share price falling lower today? (Fool)
 
The Immutep share price is falling today after the company announced its quarterly results for the September quarter. We take a closer look. The post Why is the Immutep (ASX:IMM) share price falling lower today? appeared first on Motley Fool Australi...
22.10.20 - 00:48
Immutep Activities Report for the First Quarter of Fiscal Year 2021 (GlobeNewswire EN)
 
SYDNEY, Australia, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today provided a business update for the quarter end...
21.10.20 - 19:55
Immutep nabs European patent covering IMP761 (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
21.10.20 - 16:49
Why Immutep′s Stock Is Trading Higher Today (Benzinga)
 
Immutep (NASDAQ: IMMP) shares are trading higher on Wednesday after the company was granted a European patent for its IMP761. read more...
21.10.20 - 14:06
Immutep Granted European Patent for IMP761 (GlobeNewswire EN)
 
SYDNEY, Australia, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to ann...
19.10.20 - 14:06
Immutep to Present AIPAC Overall Survival Data at the San Antonio Breast Cancer Symposium 2020 (GlobeNewswire EN)
 
SYDNEY, Australia, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune disease, is pleased to ann...
25.09.20 - 14:02
IMMUTEP Ltd: 20-F Report (SEC Filing)
 
20-F...
18.09.20 - 08:16
Immutep presents improving results from INSIGHT-004 trial (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.09.20 - 08:01
Immutep reports encouraging results from mid-stage TACTI-002 study (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
18.09.20 - 03:37
Immutep (ASX:IMM) share price flying 20% on improving trials (Fool)
 
The Immutep share price is flying today as the company reported improvements in trials relating to its leading drug IMP321. The post Immutep (ASX:IMM) share price flying 20% on improving trials appeared first on Motley Fool Australia....
18.09.20 - 02:24
Immutep Announces Improving Results from Stage I of Phase II TACTI-002 Study (GlobeNewswire EN)
 
SYDNEY, Australia, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) announces new interim data from its ongoing Phase II TACTI-002 study. The data was presented in two poster presentations at the ESMO Virtual Congress 202...
18.09.20 - 01:54
Immutep Reports Improving Results from INSIGHT-004 Trial (GlobeNewswire EN)
 
SYDNEY, Australia, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to report further interim data from its ongoing INSIGHT-004 Phase I clinical trial. The data were presented at the ESMO Virtual Congress 2020 ...
31.08.20 - 14:03
Immutep and Monash University Receive Grant Funding for LAG-3 Project (GlobeNewswire EN)
 
SYDNEY, Australia, Aug. 31, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to announce that the Australian Research Council (ARC) has awarded Immutep and research partner Monash University a A$671,427 grant under the A...
26.08.20 - 14:03
New Data From Immutep′s efti to be Presented at ESMO (GlobeNewswire EN)
 
SYDNEY, Australia, Aug. 26, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to an...
18.08.20 - 14:03
Immutep Completes Recruitment for Stage 1 of Part B in TACTI-002 Study (GlobeNewswire EN)
 
SYDNEY, Australia, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to re...
23.07.20 - 15:36
Thinking about buying stock in Entera Bio, Immutep, Electrameccanica Vehicles, Delta Air Lines, or Carnival Corp? (PR Newswire)
 
NEW YORK , July 23, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ENTX, IMMP, SOLO, DAL, and CCL....
15.07.20 - 18:19
Mid-Day Market Update: Nasdaq Turns Negative; Immutep Shares Spike Higher (Benzinga)
 
Midway through trading Wednesday, the Dow traded up 0.45% to 26763.36 while the NASDAQ fell 0.25% to 10,462.34. The S&P also rose, gaining 0.39% to 3,210.08. read more...
15.07.20 - 17:13
Immutep up 52% on U.S. patent covering LAG-3 technology (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Wie respektabel die Leut′ sind, das soll man nie auf′n ersten Blick beurteil′n, weil man sich beim zweiten nur zu oft vom Gegenteil überzeugt. - Johann Nepomuk Nestroy
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter

Copyright @ Boersentreff.de - Die Märkte im Blick!